US Drug Recall Register

FDA Drug Recalls

17,898 recalls, newest first

Class II · Moderate risk Ongoing

Carbidopa

Reason Product mix up: complaint received that sealed medication bottle contained Carbidopa, Levodopa, and Entacapone film-coated tablets (37.5 mg/150 mg/200 mg) instead of labelled lower strength Carbidopa, Levodopa, and Entacapone film-coated tablets (25 mg/100 mg/200 mg).

Rising Pharma Holding, Inc. NDC 16571-691-01 D-0029-2026
Class II · Moderate risk Ongoing

Desipramine Hydrochloride Tablets

Reason CGMP Deviations: N-Nitroso Desipramine impurity exceeding the permissible acceptable daily intake level.

Heritage Pharmaceuticals Inc NDC 23155-583-25 D-0112-2026
Class II · Moderate risk Ongoing

Desipramine Hydrochloride Tablets

Reason CGMP Deviations: N-Nitroso Desipramine impurity exceeding the permissible acceptable daily intake level.

Heritage Pharmaceuticals Inc NDC 23155-582-01 D-0111-2026
Class II · Moderate risk Ongoing

Desipramine Hydrochloride Tablets

Reason CGMP Deviations: N-Nitroso Desipramine impurity exceeding the permissible acceptable daily intake level.

Heritage Pharmaceuticals Inc NDC 23155-581-01 D-0110-2026
Class II · Moderate risk Ongoing

Desipramine Hydrochloride Tablets

Reason CGMP Deviations: N-Nitroso Desipramine impurity exceeding the permissible acceptable daily intake level.

Heritage Pharmaceuticals Inc NDC 23155-580-01 D-0109-2026
Class II · Moderate risk Ongoing

Desipramine Hydrochloride Tablets

Reason CGMP Deviations: N-Nitroso Desipramine impurity exceeding the permissible acceptable daily intake level.

Heritage Pharmaceuticals Inc NDC 23155-579-01 D-0108-2026
Class II · Moderate risk Ongoing

Desipramine Hydrochloride Tablets

Reason CGMP Deviations: N-Nitroso Desipramine impurity exceeding the permissible acceptable daily intake level.

Heritage Pharmaceuticals Inc NDC 23155-578-01 D-0107-2026
Class II · Moderate risk Ongoing

Tavaborole Topical solution 5%

Reason Discoloration

Viona Pharmaceuticals INC NDC 72578-102-04 D-0016-2026
Class II · Moderate risk Ongoing

Testo-100 Ciii

Reason Lack of Assurance of Sterility: Potential microbial contamination of subcutaneous pellets.

Advanced Pharmaceutical Technology, Inc. NDC 57377-100-01 D-0258-2026
Class II · Moderate risk Ongoing

Zicam" Medicated Fruit Drops Elderberry Flavor

Reason Labeling: Label Mix-up: The product in the bottle contains elderberry and the label failed to indicate the inclusion of elderberry as an ingredient.

Church & Dwight Co., Inc. NDC 10237-469-25 D-0095-2026
Class II · Moderate risk Ongoing

Ketorolac Tromethamine Injection

Reason Presence of Particulate Matter: Particulate matter identified as glass

Aspiro Pharma Limited NDC 31722-307-25 D-0036-2026
Class II · Moderate risk Ongoing

Medline

Reason Subpotent Drug

Medline Industries, LP NDC 55329-811-30 D-0035-2026
Class II · Moderate risk Ongoing

Doxycycline Hyclate Tablets

Reason Failed dissolution specifications: Stability testing found that the lot did not meet dissolution specifications.

Acella Pharmaceuticals, LLC NDC 42192-501-05 D-0014-2026
Class II · Moderate risk Ongoing

Afco

Reason cGMP deviations: The recall was initiated because required receipt testing of incoming alcohol components used to manufacture the listed hand sanitizers was not performed, so methanol risk could not be excluded.

Acuity Specialty Products, Inc. D-0005-2026
Class II · Moderate risk Ongoing

Wyandotte

Reason cGMP deviations: The recall was initiated because required receipt testing of incoming alcohol components used to manufacture the listed hand sanitizers was not performed, so methanol risk could not be excluded.

Acuity Specialty Products, Inc. D-0004-2026
Class II · Moderate risk Ongoing

Succinylcholine Chloride Injection

Reason Out-of-Specification (OOS) result during the 6-month stability testing; decreased preservative concentration.

Dr. Reddy's Laboratories, Inc. D-0008-2026
Class II · Moderate risk Ongoing

Aloe Up Sport Performance Sunscreen Lotion SPF 30

Reason cGMP deviations: the firm released and distributed product which failed total aerobic microbial count testing.

SV Labs Prescott Corporation D-0022-2026
Class II · Moderate risk Ongoing

Entecavir Tablets

Reason Failed impurity/degradation specifications:Out of Specification result for an individual organic impurity

Zydus Pharmaceuticals (USA) Inc NDC 68382-921-06 D-0002-2026
Class II · Moderate risk Ongoing

Entecavir Tablets

Reason Failed impurity/degradation specifications:Out of Specification result for an individual organic impurity

Zydus Pharmaceuticals (USA) Inc NDC 68382-920-06 D-0001-2026
Class II · Moderate risk Ongoing

Fentanyl citrate

Reason CGMP Deviations: Revised interpretation of Acceptable Quality Level (AQL) results.

Park Avenue Compounding NDC 83863-4272-1 D-0178-2026
Class II · Moderate risk Ongoing

Sting Relief Swabs

Reason Product Mix-up

Acme United Corporation D-0122-2026
Class II · Moderate risk Ongoing

Atorvastatin Calcium Tablets USP

Reason Failed Dissolution Specifications

Ascend Laboratories, LLC NDC 67877-514-90 D-0020-2026
Class II · Moderate risk Ongoing

Atorvastatin Calcium Tablets USP

Reason Failed Dissolution Specifications

Ascend Laboratories, LLC NDC 67877-512-90 D-0019-2026
Class II · Moderate risk Ongoing

Atorvastatin Calcium Tablets USP

Reason Failed Dissolution Specifications

Ascend Laboratories, LLC NDC 67877-513-90 D-0018-2026